Michelson Prizes laureates are distinguished scientists that have been recognized for their research and work to chart the future of human health.
Dennis Schaefer-Babajew, M.D., Ph.D.
Michelson Prizes: Next Generation Grants | 2023 Winner
As a Clinical Scholar, Dr. Schaefer-Babajew will study the effects of passively administered neutralizing SARS-CoV-2 antibodies on subsequent adaptive immune responses to SARS-CoV-2 vaccination in healthy adult volunteers.
Rockefeller University - Clinical Scholar, Laboratory of Molecular Immunology
Siyuan Ding, Ph.D.
Michelson Prizes: Next Generation Grants | 2023 Winner
Dr. Ding’s proposed research seeks to develop a combined vaccine for the leading viral and bacterial agents that cause infant diarrhea.
Washington University - Assistant Professor, Department of Molecular Microbiology
Claire Otero, Ph.D.
Michelson Prizes: Next Generation Grants | 2023 Winner
Dr. Otero’s research involves creating an effective vaccine for CY-TO-MEGLO-VIRUS or CMV. CMV is related to viruses that cause chickenpox, herpes simplex, and mononucleosis.
Weill Cornell Medical College, Postdoctoral Associate in Pediatrics
Noam Auslander, Ph.D., Assistant Professor
Michelson Prizes: Next Generation Grants | 2022 Winner
Dr. Noam Auslander is developing an artificial intelligence-based approach to efficiently detects microbial expression in cancer and immune diseases.
Assistant Professor, Molecular & Cellular Oncogenesis Program | The Wistar Institute
Jenna Guthmiller, Ph.D., Assistant Professor
Michelson Prizes: Next Generation Grants | 2022 Winner
Dr. Jenna Guthmiller’s successful proposal will map the preexisting human B cell repertoire within the draining lymph nodes of the upper and lower respiratory tract that bind and respond to next-generation influenza vaccines.
Assistant Professor, Dept. of Immunology & Microbiology, University of Colorado Anschutz School of Medicine
Romain Guyon, Ph.D., The Jenner Institute, University of Oxford
Michelson Prizes: Next Generation Grants | 2022 Winner
Romain Guyon uses a novel microfluidics system to generate biodegradable particles that can deliver priming and booster vaccines as a single injection.
Ph.D., The Jenner Institute, University of Oxford
